Navigation Links
Sagent Pharmaceuticals Launches Cefazolin for Injection, USP
Date:3/13/2008

SCHAUMBURG, Ill., March 13 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company today announced that it has launched Cefazolin for injection, USP, an essential antibiotic used to treat serious infections. Sagent's Cefazolin for injection will be available in 1g single dose vials and 10g pharmacy bulk package vials. According to IMS data, sales of Cefazolin in the United States in 2006 were approximately $69 million.

The introduction of Cefazolin for injection marks the second product launch in three months from Sagent's pipeline of more than 200 products. The launch of Cefazolin for injection follows Sagent's December 2007 introduction of the first full-line of latex-free, multi-source prefilled, ready-to-use, 6 mg and 12 mg, adenosine syringes in the market. Sagent will begin marketing and shipping Cefazolin immediately.

"The launch of Cefazolin, the first product to emerge from our extensive anti-infective pipeline, marks further progress toward Sagent's ultimate goal of becoming a leader in the injectables marketplace," said Jeffrey M. Yordon, chief executive officer, founder, and chairman of the board of Sagent. "This product provides our customers another sourcing option for this important antibiotic and, as with all Sagent products, offers enhanced labeling intended to optimize product safety and increase efficiency in the hospital."

About Cefazolin

Cefazolin for injection, USP, is the generic equivalent of GlaxoSmithKline's ANCEF(R), an antibiotic used to treat bacterial infections. Cefazolin for injection, USP, is indicated for serious infections such as those of the respiratory, biliary and urinary tracts, skin and skin structure infections, bone and joint infections, and other infections caused by various strains of streptococci. Prophylactic Cefazolin for injection, USP, preoperative, intraopertative and postoperative administration can be effective in reducing the incidence of
'/>"/>

SOURCE Sagent Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
2. Sagent Pharmaceuticals, Inc. to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
3. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
4. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
7. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
11. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2008)...STON, Oct. 11 /PRNewswire-USNewswire/ -- MedImmune... the American Academy of Pediatrics (AAP),2008 Nat...any,s growing,body of research into the prevention...ause of viral respiratory infection among preterm ...te the burden of RSV disease on,preterm babies, th...
(Date:10/10/2008)...MERYVILLE, Calif., Oct. 10 /PRNewswire-FirstCall/ ...sdaq: NTII ), today announced it will hold a,conf...pdate on the,Viprinex(TM) (ancrod) Phase 3 Trial P... will be Paul E. Freiman, president and chief exec...al officer., -- Date: Monday, October 13, 2008...
(Date:10/10/2008)...ORPUS CHRISTI, Texas, Oct. 10 /PRNewswire-FirstCal...: CTGI), a technology management,company, announce....S.,patent. The approval is on a key divisional ap...by Passing High Frequency Electric Current,Thereth...e Connects ("LTC"),platform tissue bonding/welding...
(Date:10/10/2008)...ANTA CLARA, Calif., Oct. 10 /- Finess...d control solutions for life science process,appli...eir E-Commerce Store,that makes shopping for senso...e found at the Finesse web site ( http://www.fines...chase bioprocess sensors and accessories,on-line, ...
Breaking Biology Technology:MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease 2MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease 3MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease 4MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease 5Neurobiological Technologies Announces Update Call on Viprinex (TM) Phase 3 Trial Program 2CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved 2CSMG Technologies Announces Key Fifth U.S. Tissue Bonding/Welding Patent Approved 3
...ill assume duties as director of the state Depart...merce Secretary Cory Nettles announced the hire ...initiative. , ,Part of the key to our successful ...ty really lie in collaborative efforts. We hope to...sted in starting technology businesses to the righ...
...e it, not all technologists are the life of the pa...r respective fields and even visionary in how they... and networking isnt often their strength. In fact...How do you know when two techies are talking? They...was no time for shoe-staring at Connections: Chip...
...Gov. Jim Doyle took office last year he faced the ... a gap of nearly 3.2 billion dollars and a challe...vernor. , ,However, at the 2004 Governors Confere...ssed a crowd of industry and civic representatives...industry has helped raise the state beyond its tro...
... is a nation deeply imbued with Confucian values, ... from ancestors and should never be tampered with....l last week when South Korean researchers announce...an embryo and then collect from it master stem ce...w their own replacement tissues. , ,For every Sout...
Other Biology Technology:Nettles Names Christenson as Director of Bureau of Entrepreneurship 2Pushing the Fast-Forward Button on Networking Does It Work? 2Doyle Preaches Importance of Tech Industry at Summit 2How Wisconsin Can Maintain Its Lead in Stem Cell Research 2How Wisconsin Can Maintain Its Lead in Stem Cell Research 3
(Date:10/12/2008)...ogy journal (October 12th) reveals how scientists...t UCL are using a novel nanomechanical approach to...e few antibiotics that can be used to combat incre...earchers, led by Dr Rachel McKendry and Professor ...apable of providing new insight into how antibioti...
(Date:10/10/2008)... world,s top scientists and clinicians in the huma...resent their latest research findings at the 58th ...enetics (ASHG) from Tuesday, November 11, through ...Convention Center., Founded in 1948, ASHG is the ...uman genetics,specialists worldwide, representing...
(Date:10/10/2008)...Governor Jim Doyle today announced a historic coll...ions to advance personalized health care leading t... The Wisconsin Genomics Initiative is a collaborat...edical College of Wisconsin (MCW), University of W...MPH) and UW-Milwaukee (UWM). , Wisconsin is a le...
(Date:10/10/2008)...l, will be the focus of the Society for Nutrition ...e event is just one small step in fighting world h... the world and requires immediate attention in ord..., hunger and deficiencies. The Society for Nutriti...public to get involved and make a difference in th...
Breaking Biology News(10 mins):Nanotechnology boosts war on superbugs 2The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia 2The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia 3The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia 4The American Society of Human Genetics hosts 58th Annual Meeting in Philadelphia 5Governor Doyle announces historic genomic research collaboration 2World Food Day brings attention to food security around the globe 2Rigel to Present at BIO CEO 26 Investor Conference 3058 1Dangerous Condition Underscores Importance of Home Blood Pressure Monitoring 11104 1Dangerous Condition Underscores Importance of Home Blood Pressure Monitoring 11104 2Dangerous Condition Underscores Importance of Home Blood Pressure Monitoring 11104 3Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results 3057 1Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results 3057 2Rapid Growth of Asia Pacific Clinical Trials Market Focus of New CenterWatch Report 1327 1Rapid Growth of Asia Pacific Clinical Trials Market Focus of New CenterWatch Report 1327 2Rapid Growth of Asia Pacific Clinical Trials Market Focus of New CenterWatch Report 1327 3
...y comparing 140 sequenced bacterial genomes, resea...s essential to bacterial replication ?and they did.... , Mikhail Gelfand, a Howard Hughes Medical Inst...ute for Information Transmission Problems (IITP) i...onov, used comparative genomics to identify a new ...
... first-of-its-kind multi-center trial has shown th...hildren who suffered traumatic brain injury. , The... Pittsburgh neurosurgeon P. David Adelson, MD, and...te hypothermia initiated after severe traumatic br...n for children. , TBI initiates several metabolic...
...he 2004-2005 flu season was at least as severe as ...o data from Solucient, a leading provider of healt...ted the most recent flu season from being even wor...ital admissions for community-acquired pneumonia (...flu. Solucient analyzed CAP discharge data from Oc...
...esearch into a new treatment for nerve damage caus...iabetic patients, say experts. , The treatment mi...and feet if early effects on nerve protection and ...e in diabetes is the major cause of non-traumatic .... , Scientists at The University of Manchester, wo...
Other Biology News:Bioinformatics reveals new gene regulation system 2Bioinformatics reveals new gene regulation system 3Study Finds Moderate Hypothermia A Safe Treatment For Traumatic Brain Injury In Kids 2Diabetic nerve therapy shows 'striking' results 2
Lingo-1 (K-13)
HIF-1 beta (ARNT1) Purified Anti-Mouse, Anti-Rat, Anti-Human clone 29, Isotype Mouse IgG 1 , 50 µg Consult technical datasheet for details.
MOUSE ANTI PORCINE SLA 1:FITC Immunogen: Porcine peripheral blood mononuclear cells.
An excellent carbonyl-reactive FRET quencher paired with Trp or Tyr. Minimum Purity: 95%. Abs(max): ~350 nm; Em(max): none. Solvent System:DMSO or DMF.
Biology Products: